An Unverified Reader Report on QSC Peptidology Purity Complaints

This site's editorial team received a private message from a reader describing purity test discrepancies with products purchased from QSC Peptidology, a research-peptide seller covered in our earlier piece on that industry. We're publishing a short note on it here — with the caveats up front, not buried at the bottom.

According to the message, a U.S.-based buyer purchased and independently tested 16 batches from the site: 11 came back at the company's advertised 99% purity, and 5 came back lower, at 96%. The buyer says they raised this with QSC Peptidology's staff, who attributed the gap to differences between testing labs and methods, and said any batch with a third-party report below 99% purity qualifies for a full refund.

We received this secondhand, by private message, with no link to a public post, no test reports, and no way to confirm the sender's identity or that the exchange happened as described. We have not independently corroborated any part of it — the batch count, the test results, or the staff response. Treat everything above as an unverified claim relayed to us, not a confirmed finding.

Separately from this specific claim: HPLC purity results can genuinely vary a few percentage points between labs depending on column type, mobile phase, detection wavelength, and integration method, and batch-to-batch variation is a known feature of peptide manufacturing generally. That's background information about how purity testing works, not a statement about whether this particular report is accurate.

This doesn't change our standing position: research-labeled peptides aren't dispensed against a prescription, aren't independently verified for an individual buyer, and this site doesn't recommend sourcing GLP-1 or related peptide drugs through that channel. If verifiable documentation of this specific claim surfaces — a public post, an actual test report — we'll revisit this item.